Search

Search Results

• COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis

  Selim SAYIN

  e2024016

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.016

  1385

  PDF: 1308

  HTML: 100

• EPIDEMIOLOGY OF CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE INFECTIONS IN MEDITERRANEAN COUNTRIES

  Corrado Girmenia, Martina Canichella, Alessandra Serrao

  e2016032

  2016-06-01

  https://doi.org/10.4084/mjhid.2016.032

  4944

  PDF: 1590

  HTML: 2381

• INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

  Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund

  e2009028

  2009-12-28

  1082

  PDF: 613

  HTML: 4379

• A PROSPECTIVE STUDY OF BRUCELLOSIS IN CHILDREN: RELATIVE FREQUENCY OF PANCYTOPENIA

  Mohamed El Koumi, Mona Afify, Salha Al-Zahrani

  e2013011

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.011

  2191

  PDF: 836

  HTML: 4017

• NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria

  Jonathan Braue, Vagishwari Murugesan, Steven Holland, Nishit Patel, Eknath Naik, Jennifer Leiding, Abraham Tareq Yacoub, Carlos N Prieto-Granada, John Norman Greene

  e2015010

  2014-12-27

  https://doi.org/10.4084/mjhid.2015.010

  1707

  PDF: 1100

  HTML: 10697

  Untitled: 189

• PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD

  Beatrice Autino, Yolanda Corbett, Francesco Castelli, Donatella Taramelli

  e2012061

  2012-10-04

  https://doi.org/10.4084/mjhid.2012.061

  4506

  PDF: 1925

  HTML: 17788

• BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

  Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli

  e2016011

  2016-02-10

  https://doi.org/10.4084/mjhid.2016.011

  4305

  PDF: 1483

  HTML: 3619

• Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia

  Francesco Marchesi, Fabrizio Ensoli, Irene Terrenato, Elena Papa, Fulvia Pimpinelli, Grazia Prignano, Antonio Spadea, Ilaria Cavallo, Enea Gino Di Domenico, Luigi Toma, Andrea Mengarelli

  e2020065

  2020-09-07

  https://doi.org/10.4084/mjhid.2020.065

  7845

  PDF: 723

  HTML: 216

• AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS

  Pavankumar Tandra, Jairam Krishnamurthy, Vijaya Bhatt, Kam Newman, James O Armitage, Mojtaba Akhtari

  e2013068

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.068

  2182

  PDF: 1199

  HTML: 3741

• Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study

  R.A. Stuurman, E. Jong, P.C.R. Godschalk, M.F. Corsten, J.E. Nagtegaal

  e2023067

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.067

  991

  PDF: 455

  HTML: 135

• The First Case of Concomitant Mycobacterium genavense lymphadenitis and EBV-positive lymphoproliferative disorder

  Yusuke Ito, Kensuke Takaoka, Kazuhiro Toyama, Yoshitaka Wakabayashi, Aya Shinozaki-Ushiku, Aiko Okazaki, Kinuyo Chikamatsu, Satoshi Mitarai, Tetsuo Ushiku, Mineo Kurokawa

  e2020035

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.035

  1082

  PDF: 734

  HTML: 231

• EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever

  Cumali Yalçın, Fahir Özkalemkaş, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Merve Nur Akyol, Nevriye Gül Ada, Cüneyt Özakın, Esra Kazak, Halis Akalın, Rıdvan Ali

  e2022039

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.039

  1463

  PDF: 1062

  HTML: 217

• DECOLONIZATION OF INTESTINAL CARRIAGE OF MDR/XDR GRAM-NEGATIVE BACTERIA WITH ORAL COLISTIN IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: RESULTS OF A RANDOMIZED CONTROLLED TRIAL

  Igor Stoma, Igor Karpov, Igor Iskrov, Svetlana Krivenko, Anatoly Uss, Svetlana Vlasenkova, Irina Lendina, Veronika Cherniak, Dmitrii Suvorov

  e2018030

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.030

  2863

  PDF: 894

  HTML: 305

• THE RELATIONSHIP BETWEEN PERIODONTAL DISEASE (PD) AND CARDIOVASCULAR DISEASE (CVD).

  Maurizio Trevisan, Joan Dorn

  e2010030

  2010-10-01

  https://doi.org/10.4084/mjhid.2010.030

  1820

  PDF: 1063

  HTML: 1435

• GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey

  Mehmet Hilmi DOGU, Ali Irfan Emre TEKGUNDUZ, Burak DEVECI, Gulten KORKMAZ, Melda COMERT, Omur Gokmen SEVINDIK, Osman YOKUS, Istemi SERIN

  e2023031

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.031

  1422

  PDF: 904

  Suppl. Files: 455

  HTML: 237

• Successful Management of Steroid-Resistant cutaneous Acute Graft-versus-Host Disease, Toxic Epidermal Necrolysis-Like, with Ruxolitinib

  Fahir Ozturk, Mehmet Sezgin Pepeler, Esra Ucaryilmaz Ozhamam, Gulten Korkmaz

  e2025020

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.020

  928

  PDF: 895

  HTML: 87

• IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti

  e2016057

  2016-10-25

  https://doi.org/10.4084/mjhid.2016.057

  4336

  PDF: 1110

  HTML: 1422